{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:51:37Z","timestamp":1761058297375},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1993,3,1]],"date-time":"1993-03-01T00:00:00Z","timestamp":730944000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharm World Sci"],"published-print":{"date-parts":[[1993,3]]},"DOI":"10.1007\/bf01874087","type":"journal-article","created":{"date-parts":[[2005,7,2]],"date-time":"2005-07-02T18:06:00Z","timestamp":1120327560000},"page":"79-82","source":"Crossref","is-referenced-by-count":3,"title":["Pharmacokinetics and clinical study of cefotetan in bile: Prophylactic use in biliary tract surgery"],"prefix":"10.1007","volume":"15","author":[{"given":"P.","family":"Cherrier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Perrin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Gueye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. M.","family":"Bosio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Tinel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Blot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Richer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Fauvelle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01874087_CR1","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/jac\/11.suppl_A.193","volume":"11","author":"HK Adam","year":"1983","unstructured":"Adam HK, Houghton HL, Yates RA, Young J, Donnelly RJ. Pharmacokinetics and tolerance of a 24 h infusion of cefotetan disodium (with and without loading dose) in normal Caucasian volunteers. J Antimicrob Chemother 1983;11:193\u20139.","journal-title":"J Antimicrob Chemother"},{"key":"BF01874087_CR2","first-page":"195","volume-title":"L'antibiogramme","author":"P Courvalin","year":"1985","unstructured":"Courvalin P, Goldstein F, Philippon A, Sinot J. L'antibiogramme. 3rd ed. Paris: MPC Videom, 1985:195\u20138, 219\u201324.","edition":"3rd ed"},{"key":"BF01874087_CR3","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1001\/jama.1981.03320140063033","volume":"246","author":"PD Ellner","year":"1981","unstructured":"Ellner PD, Neu HC. The inhibitory quotient. A method for interpreting minimum inhibitory concentration data. JAMA 1981;246:4.","journal-title":"JAMA"},{"key":"BF01874087_CR4","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/jac\/11.suppl_A.185","volume":"11","author":"RA Yates","year":"1983","unstructured":"Yates RA, Adam HK, Donnelly RJ, Houghton HL, Charlesworth EA, Laws EA. Pharmacokinetics and tolerance of single intravenous dose of cefotetan disodium in male Caucasian volunteer. J Antimicrob Chemother 1983;11:185\u201391.","journal-title":"J Antimicrob Chemother"},{"key":"BF01874087_CR5","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/jac\/11.suppl_A.217","volume":"11","author":"AW Owen","year":"1983","unstructured":"Owen AW, Manson JM, Yates RA, Adshead VM, Houghton HL, Tweedle DE. The pharmacokinetics of cefotetan excretion in the unobstructed biliary tract. J Antimicrob Chemother 1983;11:217\u201321.","journal-title":"J Antimicrob Chemother"},{"key":"BF01874087_CR6","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/BF01641077","volume":"11","author":"F Kees","year":"1983","unstructured":"Kees F, Strehl E, Dominiak P, Grobecker H, Seeger K, Seidel G, et al. Cefotaxime and desacetyl cefotaxime in human bile. Infection 1983;11:118\u201320.","journal-title":"Infection"},{"key":"BF01874087_CR7","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1128\/AAC.19.2.309","volume":"19","author":"JA Grion","year":"1981","unstructured":"Grion JA, Meyers BR, Hirschman SZ. Biliary concentrations of piperacillin in patients undergoing cholecystectomy. Antimicrob Agents Chemother 1981;19:309\u201311.","journal-title":"Antimicrob Agents Chemother"},{"key":"BF01874087_CR8","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1128\/AAC.13.6.985","volume":"13","author":"KR Ratzan","year":"1978","unstructured":"Ratzan KR, Baker HB, Lauredo I. Excretion of cefamandole, cefazolin and cephalothin into T-tube bile. Antimicrob Agents Chemother 1978;13:985\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"BF01874087_CR9","volume-title":"Program Abstracts of the Interscience Conference on Antimicrobial Agents Chemotherapy. Las Vegas; Nevada; 1983","author":"OV Martinez","year":"1983","unstructured":"Martinez OV, Levi JU, Malinin Tl, Zeppa R. In: Program Abstracts of the Interscience Conference on Antimicrobial Agents Chemotherapy. Las Vegas; Nevada; 1983. Washington: American Society of Antimicrobial Agents Chemotherapy, 1983:abstract 709."},{"key":"BF01874087_CR10","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/00007691-198102000-00002","volume":"3","author":"HC Neu","year":"1981","unstructured":"Neu HC. A review and summary of the pharmacokinetics of cefoperazone: a new extended spectrum of beta-lactam antibiotics. Ther Drug Monitor 1981;3:121\u20138.","journal-title":"Ther Drug Monitor"},{"issue":"Suppl","key":"BF01874087_CR11","first-page":"55","volume":"25","author":"JU Levi","year":"1981","unstructured":"Levi JU, Livingstone A, Martinez OV, Zeppa R, Malinin Tl, Hutson D, et al. Biliary concentrations of cefamandole and its use in biliary tract surgery. Scand J Infect Dis 1981;25 Suppl:55\u20137.","journal-title":"Scand J Infect Dis"},{"key":"BF01874087_CR12","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1128\/AAC.6.4.426","volume":"6","author":"KR Ratzan","year":"1974","unstructured":"Ratzan KR, Ruiz C, Irvin GL. Biliary tract excretion of cefazolin, cephalothin and cephaloridine in the presence of biliary tract disease. Antimicrob Agents Chemother 1974;6:426\u201331.","journal-title":"Antimicrob Agents Chemother"},{"key":"BF01874087_CR13","doi-asserted-by":"crossref","first-page":"176S","DOI":"10.1002\/hep.1840120131","volume":"12","author":"SM Strasberg","year":"1990","unstructured":"Strasberg SM, Harvey RPC, Hofmann AF. Bile sampling, processing and analysis in clinical studies. Hepatology 1990;12:176S-82S.","journal-title":"Hepatology"},{"key":"BF01874087_CR14","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1007\/BF01296565","volume":"37","author":"SA Ahrendt","year":"1992","unstructured":"Ahrendt SA, Magnusson TH, Pitt HA, Lillemoe KD. Effect of cholecystectomy on gallbladder bile composition. Dig Dis Sci 1992;37:1232\u20135.","journal-title":"Dig Dis Sci"},{"key":"BF01874087_CR15","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1128\/AAC.25.3.358","volume":"25","author":"OV Martinez","year":"1984","unstructured":"Martinez OV, Levi JU, Devlin RG. Biliary excretion of aztreonam in patients with biliary tract disease. Antimicrob Agents Chemother 1984;25:358\u201361.","journal-title":"Antimicrob Agents Chemother"},{"key":"BF01874087_CR16","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1128\/AAC.36.9.2057","volume":"36","author":"JWC Leung","year":"1992","unstructured":"Leung JWC, Chan CY, Lai CW, Ko TC, Cheng AFB, French GL. Effect of biliary obstruction on the hepatic excretion of imipenem-cilastatin. Antimicrob Agents Chemother 1992;36:2057\u201360.","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl","key":"BF01874087_CR17","first-page":"4","volume":"256","author":"H Tera","year":"1960","unstructured":"Tera H. Stratification of human gallbladder bilein vivo. Acta Chir Scand 1960;256 Suppl:4\u201385.","journal-title":"Acta Chir Scand"}],"container-title":["Pharmacy World & Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01874087.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01874087\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01874087","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T14:56:41Z","timestamp":1557500201000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01874087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,3]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1993,3]]}},"alternative-id":["BF01874087"],"URL":"https:\/\/doi.org\/10.1007\/bf01874087","relation":{},"ISSN":["0928-1231","1573-739X"],"issn-type":[{"value":"0928-1231","type":"print"},{"value":"1573-739X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,3]]}}}